CA
ALXN

Capitolis Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Capitolis Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,247,287
Closed -$413M – 467
2021
Q2 		$413M Buy
2,247,287
+1,005,666
+81% +$185M 4.85% 2
2021
Q1 		$190M Buy
1,241,621
+1,228,851
+9,623% +$188M 3.28% 4
2020
Q4 		$2M Buy
+12,770
New +$2M 0.03% 317